Difference between revisions of "The Compendium of Cancer Genome Aberrations"

From Compendium of Cancer Genome Aberrations
Jump to navigation Jump to search
[unchecked revision][unchecked revision]
Line 57: Line 57:
 
Browse and exchange laboratory protocols and bioinformatics analysis pipelines.
 
Browse and exchange laboratory protocols and bioinformatics analysis pipelines.
 
</div>
 
</div>
 +
</div>
 +
<div style="width: 25%; float: left;">
 +
<div style="float: left; padding-right: 10px; height: 150px;">
 +
[[File:Exclamationmark.png|64px|link=About]]
 +
</div>
 +
<div>
 +
<h4>[[Cancer Genes]]</h4>
 +
Learn about genes linked to cancer causation.
 +
</div>
 +
</div>
 +
</div>
 
</div>
 
</div>
 
<div style="width: 25%; float: left;">
 
<div style="width: 25%; float: left;">
Line 66: Line 77:
 
Learn about this project, the CGC and its members.
 
Learn about this project, the CGC and its members.
 
</div>
 
</div>
</div>
 
</div>
 
 
</div>
 
</div>
  

Revision as of 10:18, 19 January 2016


Compendium of Cancer Genome Aberrations (CCGA) is collaborative project to document and describe chromosome and other genomic abnormalities in cancer. This resource is supported by the Cancer Genome Consortium (CGC) and others with an interest in clinical cytogenetics and genomics in cancer.


Chromsosomeicon.png

Chromosome Abnormalities

Browse chromosome abnormalities found in heamtological, soft tissue and solid tumors

Copynumbericon.png

Copy Number Abnormalities

Lear about common copy number changes detected by chromosomal microarray

Cellsicon.png

Cancer Types

Browse disease sites and their associated genomic abnormalities.

Questionmark.png

Teaching

Learn about chromosome abnormalities in cancer and associated mechanistic phenomena.

Protocolicon.png

Protocols

Browse and exchange laboratory protocols and bioinformatics analysis pipelines.

Exclamationmark.png

Cancer Genes

Learn about genes linked to cancer causation.

Exclamationmark.png

Get Involved

Learn about this project, the CGC and its members.